Credit Suisse raised its price target on Outperform-rated CVS Caremark (NYSE: CVS) from $42 to $44.

The firm said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE